Skip to main content
. 2020 Nov 4;12:572086. doi: 10.3389/fnagi.2020.572086

TABLE 2.

Demographic and clinical variables.

Clinical variables NC PD-BL PD-F P-value
PD-BL/NC PD-F/NC PD-BL/PD-F
Num 82 39 39
Age (years) 59.19 ± 6.60 60.45 ± 8.09 62.10 ± 8.25 0.366a 0.038a*
Age range (years) 46–77 44–82 45–84
Gender (male/female) 47/35 16/23 16/23 0.094b 0.094b
Education (years) 9.57 ± 4.37 8.05 ± 4.53 8.05 ± 4.53 0.080a 0.080a
Disease duration (years) 3.40 ± 2.65 4.97 ± 2.71
LED 269.23 ± 232.58 460.18 ± 267.34 <0.001c*
UPDRS III 23.33 ± 13.39 19.69 ± 13.43 0.011d*
H-Y 2.5 (1.5–3) 2.5 (1–4) 0.018d*
HAMD 2.08 ± 2.47 5.13 ± 3.71 5.97 ± 4.65 <0.001a* <0.001a* 0.283c
HAMA 3.01 ± 3.50 4.59 ± 3.39 7.13 ± 5.04 0.003a* <0.001a* 0.002c*
ESS 4.98 ± 3.99 5.13 ± 4.63 5.61 ± 21.17 0.926a 0.665a 0.577c
PDSS 131.64 ± 20.91 122.77 ± 3.39 0.038c*
MMSE 28.13 ± 2.03 27.38 ± 3.17 27.15 ± 2.82 0.325a 0.028a* 0.394d

The continuous variables were represented as mean ± SD, while the categorical variable (H-Y) was presented as median (range). NC, normal control; PD-BL, PD at baseline; PD-F, PD follow-up. aMann–Whitney U-test. bPearson chi-square. cpaired t-test. dWilcoxon test. *Significant result with p < 0.05.